Fig. 2

Intraoperative view of a pseudophakic patient who developed endophthalmitis following a Dexamethasone implant (A) and removal of the Dexamethasone implant through the sclerotomy site (B)
Intraoperative view of a pseudophakic patient who developed endophthalmitis following a Dexamethasone implant (A) and removal of the Dexamethasone implant through the sclerotomy site (B)